CTOs on the Move

MicroSurgical Technology

www.microsurgical.com

 
MicroSurgical Technology is a Redmond, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

ASCENDIS PHARMA

Ascendis Pharma is focused on creating drug candidates that are improved versions of existing drugs, yielding more effective, lower-risk drugs with new patent life. Our proprietary TransCon platform is the leading, most versatile transient conjugation technology and is utilized to create clinically superior prodrugs in therapeutic areas characterized by high unmet medical need. TransCon technology creates novel long acting prodrugs of proteins, peptides and small molecules, suitable for either local or systemic treatment. Ascendis Pharma has a diversified and balanced high-value pipeline, including internal programs and partnerships together with market leaders on their key projects.

Pathway to Living

Since 1997, Pathway to Living has been helping older adults fulfill dreams and accomplish goals – every day. People are choosing Pathway as home because they need someone to guide them down their path, not stand in the way. We are the new generation of senior living – a tailored wellness program accompanied with a vibrant and inspirational way of living is what sets Pathway to Living apart from the rest. Join the movement, discover your Pathway.

Radicle Health

Radicle Health offers cannabis curriculum packages and modules for nurses, other healthcare professionals, and cannabis students at a range of price points.

Diagnocure

DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.

PLC Systems

PLC Systems is a Franklin, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.